Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Mark Doherty

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Vaccine|March 23, 2005
Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6Jan A M Langermans, T Mark Doherty, Richard A W Vervenne, et al.
European Geriatric Medicine|June 12, 2018
Vaccination programs for older adults in an era of demographic changeT Mark Doherty, Mark P Connolly, Giuseppe Del Giudice, et al.
BMC Infectious Diseases|January 21, 2012
Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden settingNovel N Chegou, Gillian F Black, Andre G Loxton, et al.
The Journal of Infectious Diseases|November 27, 2009
High heritability of antimycobacterial immunity in an area of hyperendemicity for tuberculosis diseaseAurelie Cobat, Caroline J Gallant, Leah Simkin, et al.
Chest|December 31, 2009
Tuberculin skin test and in vitro assays provide complementary measures of antimycobacterial immunity in children and adolescentsCaroline J Gallant, Aurelie Cobat, Leah Simkin, et al.
Vaccine|January 25, 2011
Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infectionJaap T van Dissel, Darius Soonawala, Simone A Joosten, et al.
Vaccines|July 27, 2024
Capturing the Value of Vaccination within Health Technology Assessment and Health Economics-Practical Considerations for Expanding Valuation by Including Key ConceptsEliana Biundo, Mariia Dronova, Annie Chicoye, et al.
Clinical and Vaccine Immunology : CVI|February 10, 2006
Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosisAbebech Demissie, Eliane M S Leyten, Markos Abebe, et al.
The Journal of Experimental Medicine|November 11, 2009
Two loci control tuberculin skin test reactivity in an area hyperendemic for tuberculosisAurelie Cobat, Caroline J Gallant, Leah Simkin, et al.
Plos Neglected Tropical Diseases|June 26, 2008
Immunity against HIV/AIDS, malaria, and tuberculosis during co-infections with neglected infectious diseases: recommendations for the European Union research prioritiesDiana Boraschi, Markos Abebe Alemayehu, Abraham Aseffa, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Vaccine|March 23, 2005
Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6Jan A M Langermans, T Mark Doherty, Richard A W Vervenne, et al.
European Geriatric Medicine|June 12, 2018
Vaccination programs for older adults in an era of demographic changeT Mark Doherty, Mark P Connolly, Giuseppe Del Giudice, et al.
BMC Infectious Diseases|January 21, 2012
Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden settingNovel N Chegou, Gillian F Black, Andre G Loxton, et al.
The Journal of Infectious Diseases|November 27, 2009
High heritability of antimycobacterial immunity in an area of hyperendemicity for tuberculosis diseaseAurelie Cobat, Caroline J Gallant, Leah Simkin, et al.
Chest|December 31, 2009
Tuberculin skin test and in vitro assays provide complementary measures of antimycobacterial immunity in children and adolescentsCaroline J Gallant, Aurelie Cobat, Leah Simkin, et al.
Vaccine|January 25, 2011
Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infectionJaap T van Dissel, Darius Soonawala, Simone A Joosten, et al.
Vaccines|July 27, 2024
Capturing the Value of Vaccination within Health Technology Assessment and Health Economics-Practical Considerations for Expanding Valuation by Including Key ConceptsEliana Biundo, Mariia Dronova, Annie Chicoye, et al.
Clinical and Vaccine Immunology : CVI|February 10, 2006
Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosisAbebech Demissie, Eliane M S Leyten, Markos Abebe, et al.
The Journal of Experimental Medicine|November 11, 2009
Two loci control tuberculin skin test reactivity in an area hyperendemic for tuberculosisAurelie Cobat, Caroline J Gallant, Leah Simkin, et al.
Plos Neglected Tropical Diseases|June 26, 2008
Immunity against HIV/AIDS, malaria, and tuberculosis during co-infections with neglected infectious diseases: recommendations for the European Union research prioritiesDiana Boraschi, Markos Abebe Alemayehu, Abraham Aseffa, et al.
Pageof 10